iCAFs localised distantly from cancer cells and were characterised by lower expression of αSMA and high level of inflammatory mediators such as interleukin-6 (IL-6), IL-11, and leukaemia inhibitory factor (LIF) (Fig. 2). The gene discussed is IL6; the disease is cancer.